Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002762 · ClinicalTrials.gov registry record

Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer

A clinical trial of Breast Cancer and Perioperative/Postoperative Complications, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
1,118
Enrollment target
20
Study locations

NCT00002762: Completed study of Breast Cancer and Perioperative/Postoperative Complications, sponsored by Alliance for Clinical Trials in Oncology.

NCT00002762 is a study of Breast Cancer and Perioperative/Postoperative Complications that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,118 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002762, a study of Breast Cancer and Perioperative/Postoperative Complications, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
1,118 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Timing of breast cancer surgery may improve effectiveness of treatment and may help patients live longer. PURPOSE: Clinical trial to determine whether timing of primary surgery in relation to menstrual cycle is associated with disease-free survival 5 years after surgery in women who have stage I or stage II breast cancer.

Interventions

  • BEHAVIORAL patient interviewing to obtain menstrual history
  • PROCEDURE blood sampling

Study Locations (20)

California

  • Scripps Cancer Center at Scripps Clinic - La Jolla
  • Rebecca and John Moores UCSD Cancer Center - La Jolla

Florida

  • Baptist Regional Cancer Institute - Jacksonville - Jacksonville
  • CCOP - Mount Sinai Medical Center - Miami Beach

Georgia

  • Winship Cancer Institute of Emory University - Atlanta
  • CCOP - Atlanta Regional - Atlanta

Illinois

  • CCOP - Evanston - Evanston
  • Rockford Clinic - Rockford

Maryland

  • Franklin Square Hospital Center - Baltimore
  • Warren Grant Magnuson Clinical Center - Bethesda

Massachusetts

  • Cancer Research Center at Boston Medical Center - Boston
  • Lahey Clinic Medical Center - Burlington - Burlington

Alabama

  • MBCCOP - Gulf Coast - Mobile

Arizona

  • CCOP - Western Regional, Arizona - Phoenix

Trial Details

FieldValue
Enrollment Target 1,118 participants
Start Date 1996-06
Est. Completion 2009-10

What the finished NCT00002762 record still lists

NCT00002762 is an observational study that tracks outcomes without assigning an intervention. Its 1,118 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (60% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which patient interviewing to obtain menstrual history is the first listed.

NCT00002762 names 20 study sites across 14 states, led by California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT00002762 about?

NCT00002762 is a clinical study titled "Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer". RATIONALE: Timing of breast cancer surgery may improve effectiveness of treatment and may help patients live longer. PURPOSE: Clinical trial to determine whether timing of primary surgery in relation to menstrual cycle is associated with disease-free survival 5 years after surgery in women who have...

What is the current status of trial NCT00002762?

This trial is currently completed. The enrollment target is 1,118 participants. The study started on 1996-06. Estimated completion is 2009-10.

What conditions does trial NCT00002762 study?

This clinical trial studies the following conditions: Breast Cancer, Perioperative/Postoperative Complications.

What interventions are being tested in trial NCT00002762?

The interventions under investigation include: patient interviewing to obtain menstrual history (BEHAVIORAL), blood sampling (PROCEDURE).

Who is sponsoring clinical trial NCT00002762?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002762 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00002762's enrollment target sits among peer trials

1,118 110th of 1224 higher than 1,115 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02140255 · 1,120 participants · Phase 1

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

  • NCT06618534 · 1,120 participants · Phase 2

    Azithromycin for Meningococcal Carriage

  • NCT07164131 · 1,120 participants · Phase 4

    Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

  • NCT05691478 · 1,122 participants · Phase 2

    A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00002762, the US trial registry maintained by the National Library of Medicine. NCT00002762 (large enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.